| Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis P Sah, MC Fitzpatrick, CF Zimmer, E Abdollahi, L Juden-Kelly, ... Proceedings of the National Academy of Sciences 118 (34), e2109229118, 2021 | 445 | 2021 |
| Simulating the effect of school closure during COVID-19 outbreaks in Ontario, Canada E Abdollahi, M Haworth-Brockman, Y Keynan, JM Langley, SM Moghadas BMC medicine 18, 1-8, 2020 | 99 | 2020 |
| Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States E Abdollahi, D Champredon, JM Langley, AP Galvani, SM Moghadas Cmaj 192 (25), E666-E670, 2020 | 95 | 2020 |
| Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study A Shoukat, E Abdollahi, AP Galvani, SA Halperin, JM Langley, ... The Lancet Regional Health–Americas 28, 2023 | 10 | 2023 |
| Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study TN Vilches, E Abdollahi, LE Cipriano, M Haworth-Brockman, Y Keynan, ... BMC Public Health 22 (1), 1042, 2022 | 9 | 2022 |
| Importance of non-pharmaceutical interventions in the COVID-19 vaccination era: A case study of the Seychelles TN Vilches, P Sah, E Abdollahi, SM Moghadas, AP Galvani Journal of global health 11, 2021 | 9 | 2021 |
| Evaluation of TB elimination strategies in Canadian Inuit populations: Nunavut as a case study E Abdollahi, Y Keynan, P Foucault, J Brophy, H Sheffield, SM Moghadas Infectious Disease Modelling 7 (4), 698-708, 2022 | 2 | 2022 |
| Estimations du taux de létalité de la COVID-19 au Canada et aux États-Unis sur une période donnée E Abdollahi, D Champredon, JM Langley, AP Galvani, SM Moghadas CMAJ 192 (46), E1482-E1486, 2020 | 2 | 2020 |
| Modelling Therapeutic Vaccines E Abdollahi, A Shoukat, SM Moghadas Trends in Biomathematics: Modeling Cells, Flows, Epidemics, and the …, 2020 | 1 | 2020 |
| Assessing Control Strategies and Timelines for Mycobacterium Tuberculosis Elimination E Abdollahi | | 2023 |
| Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease in infants: A Canadian Immunisation Research Network … A Shoukat, E Abdollahi, AP Galvani, SA Halperin, JM Langley, ... medRxiv, 2023.07. 14.23292675, 2023 | | 2023 |
| Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease: A Canadian Immunisation Research Network (CIRN) Study S Moghadas, A Shoukat, E Abdollahi, A Galvani, S Halperin, J Langley | | 2023 |
| Appendix S1 Importance of non-pharmaceutical interventions in the COVID-19 TN Vilches, P Sah, E Abdollahi, SM Moghadas, AP Galvani | | |
